文献速递呼吸道感染慢阻肺

铜绿假单胞菌LasB蛋白酶靶向CFTR-IL-6-抗菌修复通路损害先天免疫

Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway.
PubMed 文献 · Thorax · 2017-08-08

该研究评估铜绿假单胞菌弹性蛋白酶LasB对上皮离子转运、先天免疫及修复的影响。体外及小鼠实验显示LasB降低CFTR表达与活性,降解IL-6和trappin-2,下调IL-6/STAT3通路抑制上皮修复;过表达IL-6和trappin-2可保护小鼠抵抗PAO1致死。

要点

  • LasB是WT PAO1分泌蛋白中最丰富的蛋白,可降低上皮CFTR表达和活性。
  • LasB降解IL-6和trappin-2,下调IL-6/STAT3通路,抑制上皮细胞修复。
  • 过表达IL-6和trappin-2通过上调IL-17/IL-22通路保护小鼠抵抗PAO1致死。

核心结论

  • PAO1 LasB是铜绿假单胞菌分泌的主要因子,调节离子转运、免疫应答和组织修复。
  • 靶向LasB或上调IL-6、trappin-2等保护因子可能对铜绿假单胞菌感染者有益。

研究设计与样本

  • 体外使用WT或CFTR突变上皮细胞(细胞系及患者原代细胞)处理WT或ΔLasB PAO1分泌组。
  • 体内使用小鼠模型评估LasB及PAO1感染效应。

主要发现

  • LasB是WT PAO1分泌组中最丰富的蛋白,降低上皮CFTR表达和活性。
  • LasB降解IL-6和trappin-2,下调IL-6/STAT3通路,抑制上皮细胞修复。
  • 小鼠鼻内滴注LasB引起显著体重下降、炎症、损伤和死亡。
  • 过表达IL-6和trappin-2通过上调IL-17/IL-22抗菌与修复通路保护小鼠抵抗WT-PAO1致死。

临床怎么用

  • 在铜绿假单胞菌感染(如呼吸机相关性肺炎、囊性纤维化、慢阻肺急性加重)中,LasB对CFTR及IL-6/STAT3通路的抑制可能参与先天免疫受损。
  • 靶向LasB或上调IL-6、trappin-2等保护因子是潜在治疗方向。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Pseudomonas aeruginosa lung infections are a huge problem in ventilator-associated pneumonia, cystic fibrosis (CF) and in chronic obstructive pulmonary disease (COPD) exacerbations. This bacterium secretes virulence factors that may subvert host innate immunity. OBJECTIVE: We evaluated the effect of P. aeruginosa elastase LasB, an important virulence factor secreted by the type II secretion system, on ion transport, innate immune responses and epithelial repair, both in vitro and in vivo. METHODS: Wild-type (WT) or cystic fibrosis transmembrane conductance regulator (CFTR)-mutated epithelial cells (cell lines and primary cells from patients) were treated with WT or ΔLasB pseudomonas aeruginosa O1 (PAO1) secretomes. The effect of LasB and PAO1 infection was also assessed in vivo in murine models. RESULTS: We showed that LasB was the most abundant protein in WT PAO1 secretomes and that it decreased epithelial CFTR expression and activity. In airway epithelial cell lines and primary bronchial epithelial cells, LasB degraded the immune mediators interleukin (IL)-6 and trappin-2, an important epithelial-derived antimicrobial molecule. We further showed that an IL-6/STAT3 signalling pathway was downregulated by LasB, resulting in inhibition of epithelial cell repair. In mice, intranasally instillated LasB induced significant weight loss, inflammation, injury and death. By contrast, we showed that overexpression of IL-6 and trappin-2 protected mice against WT-PAO1-induced death, by upregulating IL-17/IL-22 antimicrobial and repair pathways. CONCLUSIONS: Our data demonstrate that PAO1 LasB is a major P. aeruginosa secreted factor that modulates ion transport, immune response and tissue repair. Targeting this virulence factor or upregulating protective factors such as IL-6 or antimicrobial molecules such as trappin-2 could be beneficial in P. aeruginosa-infected individuals.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Saint-Criq V, Villeret B, Bastaert F, et al. Pseudomonas aeruginosa LasB protease impairs innate immunity in mice and humans by targeting a lung epithelial cystic fibrosis transmembrane regulator-IL-6-antimicrobial-repair pathway. Thorax. 2017. PMID: 28790180. doi:10.1136/thoraxjnl-2017-210298

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。